AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...

There are other reasons to pay attention to Viking Therapeutics.

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other ...

Vertex, Inc. ( (VERX)) has released its Q3 earnings. Here is a breakdown of the information Vertex, Inc. presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...

A seasoned leader in refining, renewable fuels, and clean-energy infrastructure joins Alléo as it scales its proprietary ...

AbCellera (Nasdaq: ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers ...

Vertex Pharmaceuticals Inc. VRTX shares are up during Tuesday’s premarket session following positive interim results from one of its Phase 3 trials. The stock’s rise comes as the company is reportedly ...

Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural ...

BioProcess International learned about how advanced therapy developers and manufacturers are adapting to changing ...

Unitek Learning today announced the launch of a new paramedic program in Tempe, Arizona, marking a significant expansion of ...

Secure artificial intelligence infrastructure startup Dymium Inc. today introduced GhostAI, a gateway designed to apply ...

A look at the people shaping local business and government and giving back in Brevard ...